Head of Investor Relations
Acumen Pharmaceuticals, Inc. (ABOS)Equibles does not estimate personal net worth.
Get an email with a short summary when Acumen Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ABOS alertsAlex Braun is recorded as Head of Investor Relations at Acumen Pharmaceuticals, Inc. (ABOS). Alex Braun has spoken on 14 earnings calls and 2 other investor events across 1 company, most recently for Acumen Pharmaceuticals, Inc. on October 26, 2026. Acumen Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Acumen Pharmaceuticals, Inc. includes Daniel O'Connell (CEO), Dr. George Golumbeski (Chairman and Board Member), Matthew Zuga (CFO) and 2 others.
“Well, good morning, and welcome to the Acumen Conference call to discuss our business update and financial results for the quarter-ended September 30th, 2026. With me today are Dan O'Connell, our Chief Executive Officer, and Matt Zuga, our CFO and Chief Business Officer.”
“Today, we intend to take you on a deeper dive into Acumen's value proposition as we near the Phase 2 readout for our product candidate for the treatment of early Alzheimer's disease, Cvernitab.”
“Today, we intend to take you on a deeper dive into Acumen's value proposition as we near the Phase 2 readout for our product candidate for the treatment of early Alzheimer's disease, Cvernitab.”
“Well, good morning, and welcome to the Acumen conference call to discuss our business update and financial results for the quarter ended June 30th, 2026. With me today are Dan O'Connell, our Chief Executive Officer, and Matt Zuga, our CFO and Chief Business Officer.”
“Good morning and welcome to the Acumen conference call to discuss our business update and financial results for the quarter ended March 31, 2026. With me today are Dan O'Connell, our Chief Executive Officer, and Matt Zuga, our CFO and Chief Business Officer.”
Biotechnology · Healthcare
Head of Investor Relations
